SC301 Clinic · Shin Dong-jin Analysis Report

개요 및 병원 정보

This report is the result of an in-depth analysis of SC301 Plastic Surgery Clinic, a medical institution specializing in stem cell plastic surgery located in Gangnam-gu, Seoul, Korea, and its founder, Representative Director Shin Dong-jin. SC301 Clinic is known as a first-generation hospital that introduced stem cell breast augmentation to Korea around 2006–2007. Its most significant characteristic is advocating a "regenerative medicine" approach based on academic data and clinical research, going beyond simple cosmetic surgery.

Key Summary

Expertise

Representative Director Shin Dong-jin is evaluated as a figure who has established protocols for domestic stem cell plastic surgery, having served as the President of the Korea Stem Cell Plastic Surgery Association for 10 years.

Academic Achievements

Rare for a private practitioner, he has established medical credibility by publishing consecutive papers proving the engraftment rate (approx. 75–77%) of stem cell breast augmentation in international SCI-level journals.

Key Procedures

The core procedure is Stem Cell Breast Augmentation (SVF Breast Augmentation), and the clinic also performs facial fat grafting, recycle liposuction, and anti-aging procedures.

Reputation

While patient satisfaction regarding "natural results" and "high engraftment rates" is high, the high cost, long waiting times, and strict post-operative care act as entry barriers for some patients.

Hospital Overview and Information

Establishment and History

SC301 Clinic was established around 2006–2007 and has been in operation for over 18 years. The 'SC' in the hospital name 'SC301' stands for Stem Cell, and the clinic has focused on regenerative plastic surgery utilizing stem cells since its inception.

It holds over 8,000 cumulative clinical cases of stem cell plastic surgery and possesses a system that predicts surgical prognosis by building big data based on these cases.

Location and Facilities

Address: 3rd–4th Floor, Chan & Chan Tower, 611 Yeongdong-daero, Gangnam-gu, Seoul (Samsung-dong). (Near Bongeunsa Station on Subway Line 9 and Samsung Station on Line 2)
Medical Hours: Weekdays (Mon/Tue/Thu) 09:30–19:00, Night Clinic (Wed/Fri) 09:30–20:30, Saturday 09:00–17:00. Closed on Sundays and Public Holidays.
Facility Features:
- NASA-standard air purification system (Sterile Surgery)
- In-house Cell Laboratory with professional researchers
- 3D Analysis Room for precise volume measurement

원장 프로필

Representative Director Shin Dong-jin is evaluated as a pioneer in the Korean stem cell plastic surgery market and emphasizes the aspect of a "Physician-Scientist" who combines academic activities with clinical practice.

Education and Qualifications

Graduated from Korea University College of Medicine (MD, Ph.D.)
Regular Member and Specialist of the Korean Surgical Society
Regular Member of the Korean Academy of Cosmetic Surgery and the Korean Academy of Aesthetic Medicine

Major Career

Current Representative Director of SC301 Clinic
Former President of the Korea Stem Cell Plastic Surgery Association (10 years)
Former Representative Director of Samsung Obesity Clinic
Former President of the Korea Fat Plastic Surgery Research Society
Former Director of Apgujeong Tiara Plastic Surgery

Awards and External Activities

Received the Minister of Health and Welfare Award
Received the KFDA Commissioner Award
Appeared on various broadcasts (Dr. Shin, Good Morning Information World, etc.) to provide advice on stem cell plastic surgery and breast health

Philosophy of Practice

“

Director Shin Dong-jin adheres to the principle of "limiting surgery to 2 cases per day." This is to ensure the quality and safety of the surgery by having the representative director perform the surgery directly without a shadow doctor, as the stem cell extraction and transplantation process requires a high level of concentration.

”

핵심 기술 및 주요 시술

Core Medical Technology and Academic Achievements

The biggest differentiator of SC301 Clinic is that it has proven the effectiveness of its procedures through papers published in international academic journals (SCI-level), not just marketing terms.

SCI-level Paper Publication and Engraftment Rate Verification

Aesthetic Surgery Journal Open Forum (2020): Analysis of 105 patients proved an average engraftment rate of approximately 73.7%–75.1% 6 months after surgery.
Annals of Plastic Surgery (2023): A follow-up observation of 384 patients for 18 months proved that the average engraftment rate reached 77.48%. In particular, it was revealed that the engraftment rate increases when the number of injected cells exceeds 60 million.

Patents and Technical Capabilities

Cell Counting System: Operates a protocol that measures (counts) the number of viable cells after stem cell extraction and transplants them only when meeting a certain standard (e.g., over 60 million cells).
Patents: Holds 2 registered patents related to stem cell plastic surgery, protecting its technological originality.

Major Procedures Analysis

Stem Cell Breast Augmentation (SVF Breast Augmentation)

SC301's flagship procedure involves mixing autologous fat and stem cells (SVF) and transplanting them into the breast without using implants.

Principle: Stem cells promote blood vessel formation (Angiogenesis), drastically increasing the survival rate (engraftment rate) of fat cells.
Advantages: Natural tactile feel, no foreign body sensation or implant side effects (e.g., capsular contracture), simultaneous liposuction effect.
Target: Patients resistant to implant surgery, those wanting natural volume enlargement, or those with reduced breast elasticity after childbirth.

Facial Fat Grafting

Known as 'Baby Face Surgery', it transplants fat mixed with stem cells into sunken areas of the face (forehead, cheeks, nasolabial folds, etc.).

Features: Replenishes facial volume for a youthful look.
Differentiation: Higher engraftment rate than general fat grafting, reducing the need for frequent re-surgeries; also improves skin tone.

Recycle Liposuction

Uses a handmade method rather than mechanical suction to minimize tissue damage, and harvests high-purity fat so that the suctioned fat is not discarded but can be recycled for breast or hip-up surgery.

Other Procedures

Anti-aging: Whole-body anti-aging management through stem cell intravenous injection, exosome therapy, etc.
Hip-up Surgery: Buttock volume and line correction.

평판 분석

Positive Reputation (Pros)

High Reliability and Safety: The record of 18 years without accidents and engraftment data proven by SCI papers give patients strong confidence.
Systematic Aftercare: Many evaluations note the 'Total Care System' to increase engraftment rates, including post-operative oxygen therapy, radiofrequency management, and nutritional diet management.
Natural Results: High satisfaction in implementing tactile feel and shape like one's own breasts without the artificial feeling of implants.
Friendly Medical Staff: Numerous reviews praise the consultation directors and nursing staff for being friendly and professional.

Negative/Critical Reputation (Cons)

High Cost: The cost is significantly higher than general fat grafting or implant surgery (estimated at around 7 million KRW to 15 million KRW). Some patients express doubts about the cost-effectiveness.
Consultation Waiting and Booking Pressure: Due to its fame, consultation waiting times are long, and some patients felt psychological pressure regarding same-day booking benefits.
Strict Patient Management: To increase the engraftment rate, strict requirements for weight maintenance and diet control after surgery are made, which some patients find cumbersome.

Unique Hospital Features (Unique Selling Points)

Pre/Post Management Protocols:
- Pre-op: 3D virtual plastic surgery, ultrasound examination.
- Post-op: During engraftment (approx. 3–6 months), nutritional diet guides and hyperbaric oxygen therapy are provided to aid fat cell settlement.
Transparency: Attempts to transparently disclose the stem cell extraction process and shows volume changes numerically through pre/post-operative 3D scan data.

결론

SC301 Clinic and Representative Director Shin Dong-jin are exemplary cases in the Korean cosmetic surgery market that have preempted the keyword 'Stem Cell' and sublimated it into Evidence-based Medicine rather than a simple marketing tool.

Strengths

More than 18 years of accumulated know-how in stem cell plastic surgery.
A 77.48% engraftment rate verified by SCI papers.
The principle of direct operation by the representative director ensures quality and safety.

Considerations & Target Audience

Since high costs and a long recovery and management period are required, it is analyzed as a hospital suitable for a patient group that prioritizes:

Safety Naturalness Minimization of Side Effects

This hospital appears to offer the strongest alternative for patients concerned about side effects of implant surgery (capsular contracture, rupture, etc.) or those who want liposuction and breast augmentation simultaneously.